Peroxisome proliferator-activated receptor γ recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis

Molecular Endocrinology

Volumn 20, Issue 7, 2006, Pages 1494-1505

  Iankova, Irena ^a   Petersen, Rasmus K ^d   Annicotte, Jean Sébastien ^a   Chavey, Carine ^a   Hansen, Jacob B ^d   Kratchmarova, Irina ^d   Sarruf, David ^a   Benkirane, Monsef ^b   Kristiansen, Karsten ^d   Fajas, Lluis ^a,c  

^a INSERM   (France)

^b INSTITUTE OF HUMAN GENETICS   (France)

^c HÔPITAL ARNAUD DE VILLENEUVE   (France)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; CYCLIN DEPENDENT KINASE 9; CYCLIN DEPENDENT KINASE 9 INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN T1; CYCLIN T2; DIMETHYL SULFOXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; PIOGLITAZONE; PROTEIN P55; RNA; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; GENE TARGETING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION;

3T3 CELLS; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CHO CELLS; CRICETINAE; CYCLIN-DEPENDENT KINASE 9; DICHLORORIBOFURANOSYLBENZIMIDAZOLE; GENE EXPRESSION REGULATION; MICE; PHOSPHORYLATION; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; PPAR GAMMA; PROTEIN BINDING;

EID: 33745670848     PISSN: 08888809     EISSN: 08888809     Source Type: Journal    
DOI: 10.1210/me.2005-0222     Document Type: Article

References (31)

1. Garriga J, Grana X 2004 Cellular control of gene expression by T-type cyclin/CDK9 complexes. Gene 337:15-23
2. Shore SM, Byers SA, Maury W, Price DH 2003 Identification of a novel isoform of Cdk9. Gene 307:175-182
3. Zhu Y, Pe'ery T, Peng J, Ramanathan Y, Marshall N, Marshall T, Amendt B, Mathews MB, Price DH 1997 Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev 11:2622-2632
4. Mancebo HS, Lee G, Flygare J, Tomassini J, Luu P, Zhu Y, Peng J, Blau C, Hazuda D, Price D, Flores O 1997 P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev 11:2633-2644
5. Simone C, Stiegler P, Bagella L, Pucci B, Bellan C, De Falco G, De Luca A, Guanti G, Puri PL, Giordano A 2002 Activation of MyoD-dependent transcription by cdk9/cyclin T2. Oncogene 21:4137-4148
6. Kanazawa S, Soucek L, Evan G, Okamoto T, Peterlin BM 2003 c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis. Oncogene 22:5707-5711
7. Giraud S, Hurlstone A, Avril S, Coqueret O 2004 Implication of BRG1 and cdk9 in the STAT3-mediated activation of the p21waf1 gene. Oncogene 23:7391-7398
8. Barboric M, Nissen RM, Kanazawa S, Jabrane-Ferrat N, Peterlin BM 2001 NF-κB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol Cell 8:327-337
9. Lee DK, Duan HO, Chang C 2001 Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation. J Biol Chem 276:9978-9984
10. Tian Y, Ke S, Chen M, Sheng T 2003 Interactions between the aryl hydrocarbon receptor and P-TEFb. Sequential recruitment of transcription factors and differential phosphorylation of C-terminal domain of RNA polymerase II at cyp1a1 promoter. J Biol Chem 278:44041-44048
11. Herrmann CH, Carroll RG, Wei P, Jones KA, Rice AP 1998 Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines. J Virol 72:9881-9888
12. De Luca A, Russo P, Severino A, Baldi A, Battista T, Cavallotti I, De Luca L, Baldi F, Giordano A, Paggi MG 2001 Pattern of expression of cyclin T1 in human tissues. J Histochem Cytochem 49:685-692
13. De Luca A, Tosolini A, Russo P, Severino A, Baldi A, De Luca L, Cavallotti I, Baldi F, Giordano A, Testa JR, Paggi MG 2001 Cyclin T2a gene maps on human chromosome 2q21. J Histochem Cytochem 49:693-698
14. Spiegelman BM, Flier JS 1996 Adipogenesis and obesity: rounding out the big picture. Cell 87:377-389
15. Fajas L, Fruchart JC, Auwerx J 1998 Transcriptional control of adipogenesis. Curr Opin Cell Biol 10:165-173
16. Fajas L 2003 Adipogenesis: a cross-talk between cell proliferation and cell differentiation. Ann Med 35:79-85
17. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM 1994 mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8:1224-1234
18. Tontonoz P, Hu E, Spiegelman BM 1994 Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79:1147-1156
19. Fajas L, Debril MB, Auwerx J 2001 Peroxisome proliferator-activated receptor-γ: from adipogenesis to carcinogenesis. J Mol Endocrinol 27:1-9
20. Eberhardy SR, Farnham PJ 2002 Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter. J Biol Chem 277:40156-40162
21. Napolitano G, Majello B, Lania L 2002 Role of cyclinT/Cdk9 complex in basal and regulated transcription. Int J Oncol 21:171-177 (Review)
22. Hu E, Kim JB, Sarraf P, Spiegelman BM 1996 Inhibition of adipogenesis through MAP-kinase mediated phosphorylation of PPARγ. Science 274:2100-2103
23. Adams M, Reginato MJ, Shao D, Lazar MA, Chatterjee VK 1997 Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J Biol Chem 272:5128-5132
24. Compe E, Drane P, Laurent C, Diderich K, Braun C, Hoeijmakers JH, Egly JM 2005 Dysregulation of the peroxisome proliferator-activated receptor target genes by XPD mutations. Mol Cell Biol 25:6065-6076
25. Luecke HF, Yamamoto KR 2005 The glucocorticoid receptor blocks P-TEFb recruitment by NFκB to effect promoter-specific transcriptional repression. Genes Dev 19:1116-1127
26. Gelman L, Zhou G, Fajas L, Raspe E, Fruchart JC, Auwerx J 1999 p300 interacts with the N- and C-terminal part of PPARg2 in a ligand-independent and -dependent manner respectively. J Biol Chem 274:7681-7688
27. Fajas L, Egler V, Reiter R, Hansen J, Kristiansen K, Debril MB, Miard S, Auwerx J 2002 The retinoblastoma-histone deacetylase 3 complex inhibits the peroxisome proliferator-activated receptor γ and adipocyte differentiation. Dev Cell 3:903-910
28. Hansen JB, Petersen RK, Larsen BM, Bartkova J, Alsner J, Kristiansen K 1999 Activation of peroxisome proliferator activated receptor g bypasses the function of the retinoblastoma protein in adipocyte differentiation. J Biol Chem 274:2386-2393
29. Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefebvre AM, Saladin R, Najib J, Laville M, Fruchart JC, Deeb S, Vidal-Puig A, Flier J, Briggs MR, Staels B, Vidal H, Auwerx J 1997 Organization, promoter analysis and expression of the human PPARγ gene. J Biol Chem 272:18779-18789
30. Rocchi S, Picard F, Vamecq J, Gelman L, Potier M, Zeyer D, Dubuquoy L, Bac P, Champy MF, Plunket KD, Leesnitzer LM, Blanchard SG, Desreumaux P, Moras D, Renaud JP, Auwerx J 2001 A unique PPARγ ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol Cell 8:737-747
31. Takahashi Y, Rayman JB, Dynlacht BD 2000 Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev 14:804-816